Dynamic constraints for query operations
    13.
    发明申请
    Dynamic constraints for query operations 有权
    查询操作的动态约束

    公开(公告)号:US20070130616A1

    公开(公告)日:2007-06-07

    申请号:US11296027

    申请日:2005-12-06

    Abstract: Systems, methods, and machine-readable media are disclosed for providing dynamic and/or conditional constraints on queries based on an external security policy. In one embodiment, a method is provided which comprises receiving from a user a request to access a resource. A condition clause can be read from a grant statement defined in the security policy. The grant statement can define permission for the user to access the requested resource. In some cases, the grant statement can comprise a Java Authentication and Authorization Service (JAAS) grant statement. A query associated with the requested access can be modified based on the permission granted to the user. The modified query can then be made to perform the requested access.

    Abstract translation: 公开了系统,方法和机器可读介质,用于基于外部安全策略来提供关于查询的动态和/或条件约束。 在一个实施例中,提供了一种方法,其包括从用户接收访问资源的请求。 可以从安全策略中定义的授权语句读取条件子句。 授权语句可以定义用户访问所请求资源的权限。 在某些情况下,授权语句可以包含Java认证和授权服务(JAAS)授权语句。 可以基于授予用户的权限来修改与请求的访问相关联的查询。 然后可以使修改的查询执行请求的访问。

    Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    14.
    发明申请
    Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists 审中-公开
    取代的氮杂双环己烷衍生物作为毒蕈碱受体拮抗剂

    公开(公告)号:US20070010568A1

    公开(公告)日:2007-01-11

    申请号:US10544520

    申请日:2003-02-07

    CPC classification number: C07D471/08

    Abstract: This invention relates to derivatives of substituted azabicyclo hexanes. The compound of this invention can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.

    Abstract translation: 本发明涉及取代的氮杂双环己烷的衍生物。 本发明化合物可用作毒蕈碱受体拮抗剂,可用于治疗通过毒蕈碱受体介导的呼吸道,尿路和胃肠道系统的各种疾病。 本发明还涉及制备本发明化合物的方法,含有本发明化合物的药物组合物以及通过毒蕈碱受体介导的疾病的治疗方法。

    Clay agglomeration process
    20.
    发明授权
    Clay agglomeration process 失效
    粘土凝聚过程

    公开(公告)号:US4343751A

    公开(公告)日:1982-08-10

    申请号:US186836

    申请日:1980-09-15

    Applicant: Naresh Kumar

    Inventor: Naresh Kumar

    Abstract: An agglomeration process in which clay fines alone or in combination with other materials are agglomerated to a usable pellet size for a variety of marketable end products. The clay fines are collected, prepared and blended with conditioners and/or other waste materials in the proportions necessary to produce the desired pellet characteristics. The blended materials are preweighed and measured, permitting batch feeding to the agglomerator. The agglomerated pellets are dried and screened, with the oversize pellets being passed through a granulator to reduce their size and then being rescreened, and the undersized pellets being recycled to the collecting step for reagglomeration. Hence, the process provides pellets of relatively uniform size with little or no waste from the agglomeration procedure. The pellets may be impregnated or coated with a variety of substances, including fertilizers, pesticides, odor reducing substances, and colorants to provide a variety of different end products, including cat box filler, fertilizers, soil conditioners and floor absorbent.

    Abstract translation: 单独或与其他材料结合使用的粘土粉末聚集成可用于各种可销售的最终产品的颗粒尺寸的附聚过程。 按照生产所需颗粒特性所需的比例收集,制备和与调节剂和/或其它废料混合的粘土细粉。 混合的材料被预称重和测量,允许批量进料到附聚器。 将聚集的颗粒干燥并筛分,其中过大的颗粒通过造粒机以减小其尺寸,然后被重新筛选,并且将过小的颗粒再循环到收集步骤以进行再聚集。 因此,该方法提供具有相对均匀尺寸的颗粒,很少或没有来自附聚过程的废物。 颗粒可以浸渍或涂覆各种物质,包括肥料,杀虫剂,除臭物质和着色剂,以提供各种不同的最终产品,包括猫盒填充剂,肥料,土壤调理剂和地板吸收剂。

Patent Agency Ranking